PIEKOS BRIAN (Chief Financial Officer) sold 29.8% of their position (4.47K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $60.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001815308-25-000004
Officer· Chief Financial Officer
Since Feb 2026
-4.47K
Net shares
Net seller
$60.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 19.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
New position
11/21/2025
0.00→15K
Common Stock
Direct
Shares
−4.47K
Price / share
$13.45
Trade value
$60.14K
% of position
29.8%
11/24/2025
15K→10.53K
Total
Net shares
+10.53K
Net value
-$60.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | M · Option Exercise | +15K | — | — | New position | 0.00 | 15K |
| Common Stock Direct | 11/24/2025 | S · Sale | −4.47K | $13.45 | $60.14K | 29.8% | 15K | 10.53K |
| Total | +10.53K | -$60.14K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
Held after
65K
Exercisable
—
11/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock15K shares | 11/21/2025 | M · Option Exercise | −15K | — | 65K |